Novel role for receptor dimerization in post-translational processing and turnover of the GRα

Louw, Ann ; Wilkinson, Legh ; Verhoog, Nicolette (2018)

CITATION: Wilkinson, L., Verhoog, N. & Louw, A. 2018. Novel role for receptor dimerization in post-translational processing and turnover of the GRα. Scientific Reports, 8:14266, doi:10.1038/s41598-018-32440-z.

The original publication is available at https://www.nature.com

Article

Glucocorticoids (GCs), acting via the glucocorticoid receptor (GRα), remain the mainstay therapeutic choice for the treatment of inflammation. However, chronic GC use, aside from generating undesirable side-effects, results in GRα down-regulation, often coupled to a decrease in GC-responsiveness, which may culminate in acquired GC resistance. The current study presents evidence for a novel role of the dimerization state of the GRα in mediating GC-mediated GRα turnover. Through comparing the effects of dimerization promoting GCs on down-regulation of a transfected human wild type GRα (hGRwt) or a dimerization deficient GRα mutant (hGRdim), we established that a loss of receptor dimerization restricts GRα turnover, which was supported by the use of the dimerization abrogating Compound A (CpdA), in cells containing endogenous GRα. Moreover, we showed that the dimerization state of the GRα influenced the post-translational processing of the receptor, specifically hyper-phosphorylation at Ser404, which influenced the interaction of GRα with the E3 ligase, FBXW7α, thus hampering receptor turnover via the proteasome. Lastly, the restorative effects of CpdA on the GRα pool, in the presence of Dex, were demonstrated in a combinatorial treatment protocol. These results expand our understanding of factors that contribute to GC-resistance and may be exploited clinically.

Please refer to this item in SUNScholar by using the following persistent URL: http://hdl.handle.net/10019.1/104542
This item appears in the following collections: